Back to search
FDAFDA · Food and drugs·Recall number D-0840-2020

Kushim Tablets (Gushim) 45-count packages, Label in foreign language

Published February 19, 2020 · Recall initiated: January 28, 2020

Summary

FDA records drug Class II recall D-0840-2020, published February 19, 2020 and initiated January 28, 2020. Recalling firm: B AND A TRADING CORPORATION; Status: Terminated; Reported quantity: 40 packages; Lot: Lot #: H003. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
B AND A TRADING CORPORATION
Distributor
NY & NJ only
Lot
Lot #: H003
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Kushim Tablets (Gushim) 45-count packages, Label in foreign language recalled?

Yes. FDA published recall D-0840-2020 on February 19, 2020. Reported hazard: Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine

What should I do if I have this product?

Voluntary: Firm initiated · Letter